MxT Biotech is a pioneering biotechnology company,
and the inventor of the Hydroporator®, the next-generation non-viral gene delivery platform.
MxT Biotech’s technology serves as a critical solution for CGT researchers, developers, and
manufacturers, enabling them to achieve breakthroughs with greater efficiency.
By providing this core bioengineering solution, MxT Biotech plays a vital role in supporting
CGT companies and research institutions, driving innovation in the life sciences field.
OUR VISION
At MxT Biotech, “Innovation” is at the heart of everything we do.
Driven by passion for advancing CGT & gene editing, we foster a culture of respect, where
collaboration and open communication empower us to tackle the most complex challenges.
With a deep sense of responsibility, we are committed to delivering the cutting-edge solution
that push the boundaries of life science and CGT.